https://www.taxtmi.com/news?id=32647 Partnership expands access to certified human and animal-derived hepatic and other primary cells for preclinical drug discovery and toxicology research in India, enabling supply of cryopreserved hepatocytes, hepatic and skin cells, subcellular fractions, customized cell isolation services and disease- and functional-models such as NASH and Liver 3D Spheroids to support drug metabolism, safety assessment and disease modelling while relying on AAALAC-accredited and OECD-GLP-compliant facilities to ensure quality and reproducibility. en-us Mon, 03 Feb 2025 10:46:03 +0530 Mon, 03 Feb 2025 10:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=32647 Partnership expands access to certified human and animal-derived hepatic and other primary cells for preclinical drug discovery and toxicology research in India, enabling supply of cryopreserved hepatocytes, hepatic and skin cells, subcellular fractions, customized cell isolation services and disease- and functional-models such as NASH and Liver 3D Spheroids to support drug metabolism, safety assessment and disease modelling while relying on AAALAC-accredited and OECD-GLP-compliant facilities to ensure quality and reproducibility. News - Mon, 03 Feb 2025 10:46:03 +0530 https://www.taxtmi.com/news?id=32647